{"id":836712,"date":"2025-04-11T16:33:09","date_gmt":"2025-04-11T20:33:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/"},"modified":"2025-04-11T16:33:09","modified_gmt":"2025-04-11T20:33:09","slug":"vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/","title":{"rendered":"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE"},"content":{"rendered":"

<\/p>\n

Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE<\/b><\/p>\n

WALTHAM, Mass.–(BUSINESS WIRE<\/a>)–
\nVicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on April 10, 2025, the Company received written notice (the \u201cNotice\u201d) from the New York Stock Exchange (the \u201cNYSE\u201d) indicating that the Company is no longer in compliance with the continued listing standards set forth under Section 802.01B of the NYSE\u2019s Listed Company Manual due to the fact that the Company\u2019s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company\u2019s last reported stockholders\u2019 equity was less than $50 million.\n<\/p>\n

\nAs set forth in the Notice, as of April 9, 2025, the 30 trading-day average market capitalization was approximately $47.4 million, and the Company\u2019s last reported stockholders\u2019 equity as of December 31, 2024 was less than $50 million. This notice does not impact the Company\u2019s business operations.\n<\/p>\n

\nIn accordance with applicable NYSE procedures, the Company has 45 days from the date the Notice was received to submit a plan advising the NYSE of the definitive action(s) the Company has taken, is taking, or plans to take to bring it into compliance with Section 802.01B within 18 months of receipt of the Notice. If the Company\u2019s plan is not submitted on a timely basis or is not accepted, the NYSE will initiate delisting proceedings.\n<\/p>\n

\nPending NYSE acceptance of the plan, the Company\u2019s Class A common stock will continue to be listed and traded on the NYSE during the 18-month cure period. Continued listing is also subject to the Company\u2019s compliance with other applicable NYSE requirements and to quarterly NYSE review of the Company\u2019s progress toward achieving compliance with the plan.\n<\/p>\n

\nIn the interim, the Company\u2019s Class A common stock will continue to trade on the NYSE under the symbol \u201cRBOT\u201d with the designation of \u201c.BC\u201d to indicate the status of the shares as \u201cbelow criteria,\u201d but is otherwise not immediately impacted by the Notice. The \u201c.BC\u201d indicator will be removed at such time as the Company regains compliance.\n<\/p>\n

\nThe Notice also does not affect Securities and Exchange Commission reporting obligations by the Company.\n<\/p>\n

\nThe Company is considering all available options to regain compliance with the NYSE\u2019s continued listing standards.\n<\/p>\n

About Vicarious Surgical<\/b><\/p>\n

\nFounded in 2014, Vicarious Surgical is a next-generation robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company\u2019s novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla\u2019s Khosla Ventures, Innovation Endeavors, Jerry Yang\u2019s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang\u2019s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com<\/a>.\n<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nThis press release includes \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the United States Private Securities Litigation Reform Act of 1995. The Company\u2019s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. All statements other than statements of historical facts contained herein, are forward-looking statements that reflect the current beliefs and expectations of management. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Vicarious Surgical\u2019s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the Company\u2019s ability to develop a plan to regain compliance with the continued listing criteria of the NYSE; the NYSE\u2019s acceptance of such plan; the Company\u2019s ability to execute such plan and to continue to comply with applicable listing standards within the available cure period; risks arising from the potential suspension of trading of the Company\u2019s Class A common stock on the NYSE; the approval, commercialization and adoption of Vicarious Surgical\u2019s initial product candidates and the success of its single-port surgical robot, called the Vicarious Surgical System, and any of its future product candidates and service offerings; changes in applicable laws or regulations; the ability of Vicarious Surgical to raise financing in the future; the success, cost and timing of Vicarious Surgical\u2019s product and service development activities; the potential attributes and benefits of Vicarious Surgical\u2019s product candidates and services; Vicarious Surgical\u2019s ability to obtain and maintain regulatory approval for the Vicarious Surgical System, and any related restrictions and limitations of any approved product; the size and duration of human clinical trials for the Vicarious Surgical System; Vicarious Surgical\u2019s ability to identify, in-license or acquire additional technology; Vicarious Surgical\u2019s ability to maintain its existing license, manufacture, supply and distribution agreements; Vicarious Surgical\u2019s ability to compete with other companies currently marketing or engaged in the development of products and services that Vicarious Surgical is currently marketing or developing; the size and growth potential of the markets for Vicarious Surgical\u2019s product candidates and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of Vicarious Surgical\u2019s product candidates and services and reimbursement for medical procedures conducted using its product candidates and services; the Company\u2019s estimates regarding expenses, revenue, capital requirements and needs for additional financing; Vicarious Surgical\u2019s financial performance; economic downturns, political and market conditions and their potential to adversely affect Vicarious Surgical\u2019s business, financial condition and results of operations; Vicarious Surgical\u2019s intellectual property rights and its ability to protect or enforce those rights, and the impact on its business, results and financial condition if it is unsuccessful in doing so; and other risks and uncertainties indicated from time to time in Vicarious Surgical\u2019s filings with the SEC. Vicarious Surgical cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vicarious Surgical does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250411992350\/en\/<\/a><\/span><\/p>\n

Investor Contact
\n<\/b>
Kaitlyn Brosco
\n
Vicarious Surgical
\n
Kbrosco@vicarioussurgical.com<\/a><\/p>\n

Media Inquiries
\n<\/b>
media@vicarioussurgical.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n

INDUSTRY KEYWORDS:<\/b> Technology Surgery Medical Devices Medical Supplies Other Technology Health Technology Other Health Health Robotics<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE WALTHAM, Mass.–(BUSINESS WIRE)– Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on April 10, 2025, the Company received written notice (the \u201cNotice\u201d) from the New York Stock Exchange (the \u201cNYSE\u201d) indicating that the Company is no longer in compliance with the continued listing standards set forth under Section 802.01B of the NYSE\u2019s Listed Company Manual due to the fact that the Company\u2019s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company\u2019s last reported stockholders\u2019 equity was less than … <\/p>\n

Continue reading “Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-836712","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVicarious Surgical Receives Continued Listing Standard Notice from the NYSE - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE WALTHAM, Mass.–(BUSINESS WIRE)– Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on April 10, 2025, the Company received written notice (the \u201cNotice\u201d) from the New York Stock Exchange (the \u201cNYSE\u201d) indicating that the Company is no longer in compliance with the continued listing standards set forth under Section 802.01B of the NYSE\u2019s Listed Company Manual due to the fact that the Company\u2019s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company\u2019s last reported stockholders\u2019 equity was less than … Continue reading "Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-11T20:33:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE\",\"datePublished\":\"2025-04-11T20:33:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/\"},\"wordCount\":1156,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/\",\"name\":\"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-04-11T20:33:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/","og_locale":"en_US","og_type":"article","og_title":"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE - Market Newsdesk","og_description":"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE WALTHAM, Mass.–(BUSINESS WIRE)– Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on April 10, 2025, the Company received written notice (the \u201cNotice\u201d) from the New York Stock Exchange (the \u201cNYSE\u201d) indicating that the Company is no longer in compliance with the continued listing standards set forth under Section 802.01B of the NYSE\u2019s Listed Company Manual due to the fact that the Company\u2019s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company\u2019s last reported stockholders\u2019 equity was less than … Continue reading \"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-11T20:33:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE","datePublished":"2025-04-11T20:33:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/"},"wordCount":1156,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/","name":"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-04-11T20:33:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250411992350r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vicarious-surgical-receives-continued-listing-standard-notice-from-the-nyse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/836712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=836712"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/836712\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=836712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=836712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=836712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}